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Abstract
Background: Little is known about the presentation, help seeking behaviour for breast cancer in Singapore. Nor
was there a study exploring the experience of patients in their breast cancer journey.
Methods: A qualitative interview study with thematic analysis, conducted with 36 patients.
Results: There is no clear pattern of presentation for breast cancer by cancer stage at diagnosis, age and ethnicity
in the cancer journey of this group of patients. Patients were diagnosed with early to advanced stages cancer
regardless of when they presented or took up treatment in their cancer journey. The reasons patients sought
medical attention also did not appear to differ between the stages of cancer diagnosed, ethnic and age. Without
setting a measure to define early and late presentation, we found that women shared similar experience in their
breast cancer journey, regardless of age, ethnicity and stage of cancer at diagnosis. Poor knowledge of breast
cancer (symptoms and causes); few practised regular BSE; denial of symptom; fear of hospitalisation, diagnosis and
treatment; worries and stress over financial burden of treatment; misinformation in magazine and online sources;
diet; stress; caring responsibility; support network; and use of alternative medicine before and after diagnosis were
identified in patients’ narratives. Strong social support; fear of being an emotional and financial burden for the
family; and financial worries during treatment were also the recurring themes after diagnosis.
Conclusion: A measure of breast cancer presentation - that accounts for the patient’s experience in the cancer
journey, the time interval and tumour biology – that is meaningful to patients, clinicians and researchers is needed.
For research on late and delayed presentation, details on BSE practice – how often, when and was it done correctly
– will improve the accuracy of time delay interval. For the public, concerted efforts to improve knowledge of breast
cancer, survival and prognosis for early-diagnosed cancer, and the importance of regular and correct technique to
perform BSE, are critical and urgent to address the rising breast cancer incidence in the country.
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Background
Across Southeast Asia, Singapore has the highest inci-
dence rate of breast cancer. Singapore continues to ob-
serve a significant increase in breast cancer incidence
over the years [1]. Breast cancer is the leading cancer
among Singaporean women, accounting for 20% of all
female cancers, with an age-adjusted standardised rate
(ASR) for mortality of 15.5 per 100,000. While the mor-
tality rate has decreased, the incidence rate has rapidly
increased for women over 50 years old. Overall, the inci-
dence of breast cancer is on the rise at a rate of 3%, and
the ASR on incidences has increased from 59.8 per 100,
000 (2009) to 65.7 per 100,000 (2012). Further, over 22%
of advanced stages cancer have been reported: 22.3%
(14.4% stage III and 7.9% stage IV) (1995–2007
Singapore-Malaysia Breast Cancer Hospital-based Regis-
try) [2] and 29% (19% stage III and 10% stage IV) ac-
cording to SEER data for 1975–2013 [3].
Cancer stage at diagnosis is a prognostic factor in
breast cancer survival, with an early staging of cancer
correlating with improved survival rates [4, 5]. Singapore
introduced a national mammography screening
programme, Breast Screen Singapore (BSS) in 2002 to
improve detection of early stage cancer. BSS invites
women aged 50 to 64 years old biennially for screening
[6]. Women aged 40–49 and over 64 years have access
to BBS upon request. Despite the awareness raising ini-
tiatives about mammography screening and breast can-
cer, improvement of breast care services, and strategies
to reduce financial burden, uptake of breast screening
remained poor [7]. Only 39.6% attended screening in the
previous two years, despite over 90% of women aged be-
tween 50 and 69 years being aware of mammography as
a breast cancer screening tool. Participation rate was re-
corded at 9.9% (2002–2003), increased about 4 to 13.7%
(2005–2006) but dropped to 11% in 2008–2009. Low up-
take of BSS inadvertently meant that symptomatic diag-
nosis is ever important, but survival is predicated on
patients presenting early for symptomatic cancer.
Late or delayed presentation of symptomatic cancer
for medical care is a major factor leading to an increase
in advanced breast cancer, poor prognosis and higher
treatment cost [8, 9]. Patient, healthcare provider, and
system-related factors, age, cultural beliefs, attitudes,
perception of the symptoms as serious, and anxiety have
been reported as factors influencing possible delay in pa-
tients seeking health care and treatment [10–16]. In
neighbouring country Malaysia, which has the same
population ethnic groups (Chinese, Malay and Indian) as
in Singapore, late presentation was attributed to the use
of alternative medicine, poor knowledge of symptoms,
denial, poor social support, missed diagnosis and nega-
tive attitudes towards treatment to delayed presentation
and diagnosis [17–19]. In Hong Kong, where the
population is predominantly Chinese, patients not recog-
nising non-specific atypical symptoms, time factor, bar-
riers to service access, embarrassment and treatment
cost were reported [20]. While there are studies investi-
gating the attitudes and low uptake of breast screening
among Singaporean women [21, 22], there is yet any
study investigating the help-seeking behaviour for breast
cancer among patients in Singapore.
Patients’ accounts or narratives have been used to ex-
plore and understand patients’ experience of cancer and
chronic illnesses since the late 1980s [23–29]. Within
qualitative research, narrative and thematic approaches
provide systematic means to explore the lived experience
and map the richness and wealth of information within
narratives. Patients’ account of events and lived experi-
ence thus is useful for the purpose of exploring decision
making process and action to seek help and treatment.
A qualitative approach has been successfully applied to
understand the causes and experience of breast cancer
[13, 20, 30, 31].
Several definitions have been used to describe late
presentation for cancer: delay avoidance [32], time delay
[33–36], sources of delay [37], phases of delay [13, 38]
and tumour stages [39, 40]. Of these, time delay of 3
months from symptom recognition to medical help seek-
ing is the common definition used to investigate late
presentation for breast cancer [18–20, 31, 41], and a
shorter time interval of one month has also been used
[42]. Apart from the inconsistency in the time interval,
there is also concern about the validity of a time delay
definition because of the issues of recall bias [43] and
the comparability of the results [44]. Breast cancer is a
disease that has improved prospects for survival if de-
tected and treated early. Any delay in presentation for
symptomatic breast cancer is associated with larger tu-
mours, more advanced stages of disease and conse-
quently poorer prospects for survival [8]. To avoid
validity issue due to recall bias, stage at cancer diagnosis
has been used as a proxy for time to seek medical
care, as it is recognised that those who take longer to
seek help are at a greater risk of being diagnosed at
advanced stages of cancer [45]. The term ‘advanced
stage’ (Stages III and IV) has been used to represent
late presentation of breast cancer [4, 46] but this ne-
glects the patient’s perspective of not seeking early
medical attention. The role of tumour characteristics
and aggressiveness as a prognostic factor in determin-
ing the stage of cancer is neglected when focus is
placed on patient delay and late presentation [47].
Tumour histology was found to influence the survival
of breast cancer patients who delayed hospital admis-
sion; with survival greater for cancer of lower grade
than higher grade [48]. A valid measure of presenta-
tion will need to account for all the above factors.
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This paper presents the findings of the first study in
Singapore exploring presentation of breast cancer for
medical care as experienced by patients in their cancer
journey. This study formed part of an international, multi-
centre qualitative project investigating the psycho-social
cultural aspect of breast cancer [49]. Other studies con-
ducted within this project are reported elsewhere [31, 41].
The present paper is an extension to our country com-
parison study [41], in that presentation and help seeking
behaviour for breast cancer by stage of cancer, ethnicity
and age; and experience of going through the breast can-
cer journey in Singapore are discussed in detail.
Methods
Sampling design
A nested sampling design, also a form of theoretical
sampling aiming to reach maximum variation and het-
erogeneity within the sample was employed [50, 51].
Our goal was to recruit 54 participants with breast can-
cer diagnosis from three ethnic groups (Chinese, Malay
and Indian) and three age groups (< 40 years, 40–60
years and > 60 years old), with 3 members in each sub-
group (Table 1). Previous qualitative studies investigat-
ing help seeking for breast cancer reached data
saturation between 18 to 46 participants [30].
Recruitment
Ethical approval was obtained from the National Health-
care Group Ethics Review Board, National University
Hospital (NUH), Singapore (Reference 2012/02234). Re-
cruitment of patients was conducted at the breast sur-
gery division in NUH where approximately 30% of
breast cancer patients in Singapore were managed.
Women over the age of 21 years old, diagnosed within
the last 6 months with breast cancer (Stages 1 to IV –
AJCC 7th Edition Classification,) to minimise recall bias,
were identified by their clinical team. They were invited
to participate in the study between July to December
2012. To minimise distress, we were careful only to ap-
proach the patients after they had chosen their treat-
ment plan and were deemed suitable by their primary
oncologist to participate in the study. Apart from the
English version patient information sheet (PIS), we also
prepared a version in Malay and Chinese languages - pa-
tients were provided with the version in their preferred
and/or spoken language and a research assistant who
was fluent in all the three languages (JLiu) was present
to provide explanation about the study. The women
were given 24 to 36 h to consider participation before
they were contacted by the telephone. A meeting date
that coincided with their next clinical visit was sched-
uled with women who agreed to participate. At the start
of the meeting, the research assistant explained the study
and obtained verbal informed consent from the partici-
pant; this consent was audio-recorded.
Data collection: interview guide and interviewing process
Data were collected using face-to-face interviews. A
topic guide was developed based on previous literature
[30], and piloted with 4 patients, and then further re-
fined to local context. The guide covered topics on lay
understanding of breast cancer, knowledge and aware-
ness of symptoms and causes, and decisions and behav-
iour in their journey from symptom discovery to
treatment. it followed the patient through the process of
symptom discovery, diagnosis, treatment and follow up.
Interviews lasted on average of between 30 and 60min.
All interviews were conducted in the patient’s preferred/
spoken language in a private clinic room after informed
consent was taken. This made the interview process less
intimidating, allowing a secure environment for the pa-
tient to share their experiences. All the interviews were
conducted with the patient; except for five patients (4
elderly Malay patients and 1 Indian patient) who were
interviewed in the presence of their children who helped
to relay the questions and responses. The research as-
sistant (JLiu) and CN received training on qualitative re-
search from an experienced researcher (JNWLim) for
data collection and analysis. All the researchers, except
MH were multilingual. A breast care nurse was available
for referral if the participant needed psychological ad-
vice. Participants were reimbursed for their transporta-
tion expenses.
All interviews were audio-taped, transcribed verbatim
and, Chinese and Malay transcripts were translated into
English during transcription by JLiu who did all the in-
terviews [52]. Interviews were analysed within two weeks
before the next interview began. Recruitment stopped
after data saturation was achieved.
Table 1 Nested sampling design – Singapore study
Ethni-city Malay (n = 18) Indian (n = 18) Chinese (n = 18)
Breast Cancer Stage Early Stage

















Age (years) < 40 40–60 > 60 < 40 40–60 > 60 < 40 40–60 > 60 < 40 40–60 > 60 < 40 40–60 > 60 < 40 40–60 > 60
No. to recruit 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3
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Coding and analysis
Two cycles of inductive analysis were conducted. The
interviews were transcribed and subjected to applied
thematic analysis to determine the behaviour and experi-
ence of breast cancer patients in their cancer journey
[53–55]. For inter-rater reliability, three researchers in
the team (CN, JNWLim and JLiu) read the transcripts
independently to identify coding and coded emerging
themes into parent nodes and sub-themes. They com-
pared their results and any potential disagreements were
identified and resolved following discussion within the
team. The emergent themes were then subjected to a
second level of analysis for similarities and contrasts by
stage of cancer at diagnosis (Stages I to IV), ethnicity
and age group. Summary percentages were also calcu-
lated to assist interpretation, and to place the findings in
the context of the existing literature.
The software package, NVivo (version 10) was used to
manage the data. The traditional coding approach of
‘Pen and papers’ was preferred in the second cycle of
analysis as this retained the closeness between the re-
searcher and the data.
To ensure robustness of the study, the Consolidated
criteria for reporting qualitative research (COREQ) was
used to plan and implement this study [56].
Results
Fifty-four patients were approached and 40 (74%) agreed
to participate in the study. Only 36 interviews were in-
cluded in the analysis as four were excluded due to poor
recording quality. Of the 36 female patients, 17 were
Chinese, 12 were Malay and 7 were Indian; these repre-
sented the ethnic distribution of the population in
Singapore with 75% Chinese, 14% Malay and 9% Indian.
The mean age of the participants was 54 years old
(range: 25 to 82 years old) with a majority (81%) aged 40
years old and older. Over a third of the women (13) fall
in the BSS programme’s target screening age group of
50–64 years old. Over half of the 36 participants (56%)
were diagnosed with early stages cancer while the
remaining had advanced stage cancer diagnosis. A quar-
ter of the patients presented with tumour less than 2 cm
in size, and about 60% with tumour between 2 cm to 5
cm (Table 2).
Presentation of breast cancer symptoms by ethnicity, age
and stage of cancer
The most common symptom was a palpable painless
lump in the breast regardless of ethnicity, cancer stage
at diagnosis and age. Atypical symptoms such as breast
pain, tightness and stinging in breast, larger breast size
Table 2 Characteristics of participants



















Tumour size (TNM classification) T1 (<= 2 cm) 9
T2 (> 2 cm but < 5 cm) 21
T3 (> 5 cm, no extension to chest wall) 4
T4 (any size with extension to chest wall and/or skin) 2
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and redness, swelling in breast, boil on breast, and
inverted nipple were also reported. There was no differ-
ence in the symptoms of breast cancer by age. There
were more Malay and Indian women diagnosed with
early stage cancer while more Chinese with advanced
stage cancer (Table 3).
Presentation by time delay and cancer stage
The data in Table 4 showed that time delay, i.e. interval
between symptom discovery and medical help seeking
did not reflect the stage of cancer being diagnosed. Seek-
ing medical attention early did not translate into better
prognosis. The time delay reported by women diagnosed
Table 3 Breast cancer symptoms by ethnicity, stage of cancer and age
Ethnicity Stage of cancer (n) Stage of cancer Age group Symptom(s)








Advanced Stages (9) III < 40 Lump
III < 40 Lump, bean size
III 40–49 Lump, hardness in breast,
III 50–59 Lump
III 60–69 Tightness, prickly/stinging pain and later found a lump
III 60–69 Lump
III 60–69 Lump (bony)
IV 60–69 Protruding grape size lump
IV < 40 Hard lump, until it grew bigger
MALAY Early Stages (7) I < 40 Lump
I 40–49 Lump
I 40–49 Lump
II < 40 Protruding lump on left nipple.
II 50–59 Lump
II 50–59 Lump
II 60–69 A boil of the size of a cherry on the breast
Advanced stages (5) III 40–49 Protruding lump
III 40–49 Mammography positive result
III 50–59 Lump that was painful
III 60–69 One breast bigger and red.
III ≥70 Painful lump
INDIAN Early Stages (5) I 40–49 Had an intuition and went to clinic,
Doctor didn’t find lump, she insisted then after 3rd check,
lump was found.
I 60–69 Lump (20 cent coin size)
II 40–49 Pain in breast
II ≥70 Swelling lump
II ≥70 Tiny lump,
Advanced Stages (2) III 40–49 Pain in breast
IV 60–69 Inverted nipple, skin ‘pocket’, sometimes got lump
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with early stages cancer (Stages I and II) ranges from
immediately seeking medical attention to 6 months.
Three women in this group presenting late for medical
care from 3 to 6 months and were diagnosed with Stage
II cancer. Over half of the women (9/16) who were diag-
nosed with advanced stage cancer reported delaying
medical attention from one month to one year, and one
woman said she sought medical attention immediately.
Two of the three women with advanced Stage IV said
they delayed for 2 months while the other for 7 months.
A few women with advanced stage cancer discovered
their symptoms after performing breast self-examination
(BSE). Regardless of their age, help seeking behaviour
among the women appeared to be erratic. These findings
suggest that many women did not perform breast self-
examination regularly and/or correctly, and discovery of
symptoms (painless lump) was opportunistic or by
chance.
Table 4 Stage of cancer and time delay
Ethnicity Stage of cancer Stage of cancer Age (years old) Time delay
CHINESE Early Stages I < 40 1 day
I 40–49 1 month
I 50–59 Clinic visit
I 60–69 1 day
II < 40 1 month
II 40–49 Breast self- examination (BSE), immediate
II 60–69 6 month
II 60–69 1 day
Advanced stages III < 40 1 week
III < 40 1 month
III 40–49 1 year
III 50–59 A few days
III 60–69 7 months
III 60–69 BSE, immediate
III 60–69 1 year
IV 60–69 2 months
IV < 40 2 months
MALAY Early stages I < 40 1 day
I 40–49 1 month
I 40–49 Mammogram
II < 40 1 day
II 50–59 3 months
II 50–59 Medical check up
II 6069 5 months
Advanced stages III 40–49 1 year
III 40–49 Mammography
III 50–59 5 months
III 60–69 Hospital admission for other illness/symptom
III ≥70 1 year
INDIAN Early stages I 40–49 immediate
I 60–69 1 month
II 40–49 1 day
II ≥70 6 months
II ≥70 2 months
Advanced stages III 40–49 A few days
IV 60–69 7 months
Ng et al. BMC Cancer         (2020) 20:1080 Page 6 of 15
Patients’ attitudes and experiences in their cancer
journey
The narratives of the patients told stories of their atti-
tudes and behaviour in their cancer journey from symp-
tom discovery to treatment.
A) Help seeking attitudes and behaviour for breast cancer
symptom(s)
Several themes were identified as factors influencing
presentation for breast cancer shared by women regard-
less of their age, ethnicity and stage of cancer diagnosed:
Awareness and knowledge of breast cancer
Knowledge of cancer was poor in this group of patients.
Participants had neither in-depth nor accurate know-
ledge of breast cancer prior to their diagnosis, or think-
ing that cancer is the disease of others. This can be
attributed to some extent to ineffective public education
but it is apparent that the individual’s disinterest in a
matter that they felt will not befall them played an im-
portant role.
‘I only understood it after I was diagnosed with it’
(40–49 year old Chinese female with Stage III
cancer).
‘I have no understanding of cancer as I never
thought that I would be diagnosed with it … so I
never bothered to understand it (breast cancer).’
(40–49 year old Chinese female with low educa-
tional qualifications, Stage II cancer).
‘Very poisonous. I read the news that when you find
out … it will spread. If you don’t seek treatment … it
is scary and I don’t dare to think or care about it.’
(60–69 year old Chinese female, Stage II cancer).
‘Actually I was shocked also, you know … yeah.
Didn’t know it can happen to me also … ’ (50–59
years old Chinese, Stage I cancer).
Knowledge and awareness of breast cancer symptoms
and the importance of breast self-examination (BSE)
served as barriers to help seeking for medical care.
‘It’s not life or death, I thought it was natural (to
have a breast mass), I was able to do things (and
look after the children).’ (50–59 year old Chinese
nanny with stage III cancer).
‘When I felt there was something, because it was on
the bone portion, I thought it was more the bone
than the lump’ (60–69 year old Chinese female with
stage III cancer).
Women who were aware of breast cancer and per-
formed BSE regularly sought medical attention early.
This is in contrast to women who delayed seeking help,
having poor knowledge of breast cancer symptoms and
regarded atypical symptoms as normal and oblivious of
its implications.
‘Normally I don’t massage my own breasts because I
don’t have big breasts (it should be obvious if there
is a lump)’ (60–69 year old Chinese property agent
with stage IV cancer and a 4.5 cm breast lump).
‘I try to check my breasts every day. That day, I no-
ticed something was inside so I knew there was no
need to wait, I went to the polyclinic for a check’ (<
40 year old Malay female with stage I cancer).
‘ … I raised it (breasts) up to feel, lower it to feel and
compare their sizes. Then I realized something was
not right, the right one seems to have shrunk and the
breasts have become uneven. When you put it down
you will know whether they are of the same size. It
seems weird today, something is not right. I have not
looked at them for two months as I was very busy and
suddenly I thought … die. This time I got it’ (60–69
year old Chinese female with stage II cancer).
‘I did not notice a lump but I had (breast) pain and
went to the polyclinic. They told me I had a large
lump and sent me to NUH (National University
Hospital)’ (40–49 year old Indian female with stage
III cancer).
‘I know how to check, but I never checked (my
breasts)’ (40–49 year old Indian female with stage
III cancer).
Misinformation
Sources of public education such as mass media, maga-
zines, search engines and television shows can act as an
enabler if accessible to the right population groups. Like-
wise, they can also be barriers if inaccurately presented.
‘I learnt how to examine my breasts from a television
program. I thought that if I had a lump, the shape
will definitely change … and this is true’ (60–69 year
old Chinese with Stage II cancer).
‘I went online and searched for some information. It
said that if it could move, it might be benign.’ (< 40
year old Chinese graduate with Stage III cancer).
‘One day I was reading a magazine about this
Malay lady being diagnosed with cancer and the
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symptoms of it. One of them was having a lump be-
neath the armpits. Then I happen to have a lump
beneath my armpits … Singapore had this Pink Rib-
bon event organized by the Breast Cancer Awareness
Society, giving us some information’ (< 40 year old
Chinese graduate with Stage I cancer).
It is a common norm to seek the opinions of family
members and loved ones, and then draw conclusions
based on their knowledge and experiences.
My mother had a benign lump before, she did not re-
move it and it recovered on its own. So she told me that
mine might be the same. I trust my mother’s words so I
did not seek treatment immediately. About a week
later, I pondered about it and felt the lump (< 40 year
old Chinese graduate with Stage III cancer).
Diet and stress
Diet and stress were thought to be major contributors of
cancer and general prevention of ill health by diet modi-
fication and good exercise regimes were thought to pre-
vent cancer.
‘When you talk about causes (of breast cancer) … I
have heard that I have to eat healthy … for 10 years
I did not eat McDonalds, or any fried food, I don’t
even know how to order food at those restaurants …
’ (60–69 year old Chinese with stage III cancer).
‘ … Sometimes what we eat, consume, plays a part’
(50–59 year old Malay retail assistant with recurrent
stage II cancer).
‘What causes it? Could be stress, could be your food.
I mean those kinds of things and many different fac-
tors’ (40–49 year old Chinese Librarian with stage I
cancer).
Family history of breast cancer
While most knew that genetics played a role in predis-
position of cancer, a negative family history gave them
false reassurance.
‘What we understand is that cancer is related to
(family) history and genes right? So … so that’s why
everybody just ignored, and never went for check-up
… because we believed that we were safe since our
family does not have any history of this (breast can-
cer)’. (50–59 year old Malay female with recurrent
stage II cancer).
‘I didn’t even know that one could contract this ill-
ness if there was no history of cancer in the family’
(40–49 year old Chinese female with low educa-
tional qualifications and stage II cancer).
‘The weird thing is, none of them (parents) have this, they
have diabetes, I don’t understand why I got this’ (60–69
year old Chinese administrator with Stage III cancer).
Fatality of breast cancer
Some believed that breast cancer was fatal and that the
treatment was futile.
‘Feels like once you get it, you will die from it’ (< 40
year old Chinese unemployed with stage II cancer).
‘ … But this sort of illness, to me, this kind of illness
is very scary. Even in its early stages, it is difficult to
be cured.’ (60–69 year old Chinese accountant with
stage II cancer).
‘My understanding is it could be fatal, it means it
could be quite life threatening. It is treatable, but it
is not, there is no warranty of cure once you have
cancer, any kind of cancer, inclusive of my breast
cancer.’ (60–69 year old Chinese property agent with
stage IV cancer).
Breast cancer screening
A third of the patients displayed awareness of breast screen-
ing. However, this did not translate into productive actions
due to perceived pain associated with mammograms.
‘I did not want to go for mammograms because it is
painful’ (50–59 year old Chinese nanny with stage
III cancer).
Caring duties
Women reported delaying seeking medical attention be-
cause of caring duties. Some of this could be attributed
to the cultural fixation on multiple roles of the female –
a mother, wife, daughter, provider, and friend.
‘I did not dare tell my family. I tell myself not to
bother (them). All the chemotherapy and radiother-
apy are troublesome and I would still die after (the
treatment)’ (60–69 year old Chinese female with
stage I cancer).
‘I knew about it last year, but I kept quiet. I have to
look after my husband – his cataracts (before I go
and see the doctor)’ (50–59 year old Malay house-
wife with stage III cancer).
‘If I went for surgery (5 years ago when I was still a
nanny), nobody will look after the child, things
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would be difficult for the mother.’ (50–59 year old
Chinese nanny with stage III cancer).
Fear
Fear was a recurring theme. It is an irrational emotion
that encouraged productive and counter-productive be-
havior. Women were often stunted by fear and hid be-
hind purposeful oblivious leading to delayed
presentation.
‘I realized there was something wrong (about 6
months ago), but I did not check up immediately, I
dragged it out for about 3 to 4 months … I was
afraid, what if it is a malignant tumour? Actually I
always hear from others that it should be during the
early stages when you are detected … but this sort of
illness, to me, this kind of illness is very scary.’ (60–
69 year old Chinese accountant with stage II
cancer).
‘I know that I got (cancer), and I have to go to the
hospital. I was already scared, so I postponed to see
doctor, I delayed and delayed, and then I realized …
I don’t know where to go, I cannot find out how to
cure this sickness, so finally I come here (hospital)’
(40–49 year old Malay female with stage III cancer).
‘ … knew it could be cancer, tried to dismiss the idea
away because all her life she has never been to the
hospital’ (60–69 year old Malay female with stage III
cancer).
Patient’s personality
Inherent personality traits were important factors that
could override barriers to seeking medical attention. Re-
silient and analytical personalities were evident in some
women who presented early. Though fear was unani-
mously encountered, they were able to overcome the
situation and made the sensible decision to seek help
early.
‘On one hand I was very scared I would die … but I
thought that the most important thing would be to
heal myself first’ (40–49 year old Chinese female
with low educational qualifications and stage II
cancer).
‘I panicked, thinking if this could be cancer … I tried
to remain calm and immediately went to the clinic’
(60–69 year old well-read Chinese female with stage
III cancer).
‘After you find a (breast) lump, be it good or bad,
you should accept it and seek treatment
immediately’ (60–69 year old Chinese accountant
with stage II cancer).
Fear of dying in the hospital
Two elderly Malay patients conceived their symptom
from their family because they believed that they would
die lonely in the hospital.
‘ … I would die there (hospital). I could tell my son, I
kept this secret until it was too painful … ’ (over 70
year old, Malay, Stage III cancer).
‘I might die in the hospital if I go there’ (over 70 year
old, Malay, Stage II cancer).
Traditional and alternative medicine
The easy accessibility of traditional and alternative medi-
cine locally is a double-edged sword. Patients often
choose to subscribe to alternative medicine believing in
its curative effect, thus delaying presentation.
‘I decided to wait and see, I was doing some alterna-
tive treatments, diet, exercise and you know, good
healthy lifestyle. I stopped taking sweets and meat …
’ (60–69 year old Indian Housewife with stage IV
cancer).
‘I went to the traditional Chinese medicine doctor
first (after being diagnosed at the polyclinic)’.
(< 40 year old Chinese graduate with stage IV
cancer)
‘ … I’m now looking for a traditional and alternative
medicine to improve my health, as there are many
side effects after chemotherapy, like cough. After my
second chemotherapy, I had a cough and it did not re-
cover for two months. After that I went to see a TCM
until now.’ (< 40 year old, Chinese, Stage III cancer).
Financial burden
Healthcare in Singapore is a fee for service system. A
few patients decided to wait because they were worried
about the financial burden placed on themselves and
their family. One waited until she was offered a job.
I really did not want to see the doctor when I found
the lump. The treatment cost is expensive in
Singapore. I have Medisave and my son also has
saving. But it would be a lot of money. I waited and
hope it would go away. When I finally had treat-
ment, they told me I am qualified for government
subsidy, I have no knowledge of this subsidy. Now I
am in the clinical trial. (60–69 year old, Chinese,
Stage II cancer).
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‘I thought of seeing the family doctor but that would
be expensive. How much is one (referral) letter? Bet-
ter not. Let’s go poly (clinic).’ (60–69 year old, Chin-
ese, Stage II cancer).
‘If you fail your medical check-up, they (the em-
ployer) will terminate you, so I wanted to check after
I got the job’ (50–59 year old, Malay, Stage II
cancer).
Family support
Family members acted as the motivating factor for
women to seek help for their symptom(s).
‘Initially I told my children not to bother about it, but
later I thought about it and I think it is better to see a
doctor as my grandchildren are so young and cute, and I
cannot bear to leave them. She (my daughter) said
“Mum, I will take the day off and bring you”.’ (60–69
years old, Chinese, Stage I cancer).
‘I had the symptom, a lump, for a while. I found it
while I was holidaying in Indian. Then I visited my
son in the US and told him. He scolded me and told
me to see the doctor immediately. I came back to
Singapore and went to the doctor’ (60–69 year old,
Indian, Stage IV cancer).
B) Patients’ experience after diagnosis and during
treatment.
Women told their experience after they were diagnosed
with breast cancer, and the coping strategies they
adopted during treatment.
Acceptance of cancer
Older patients expressed acceptance of diagnosis and
fate, while a young patient expressed shocked.
‘There’s nothing much. If I have to face the later
stages of (cancer) that cannot be treated and will
lead to death, there’s nothing we can grumble about.
To put it plainly, if your time is up … you have to
take care of yourself. Such problems cannot be pre-
vented.’ (60–69 year old, Chinese, Stage I cancer).
‘ … I was struggling the past few months, therefore I
was mentally prepared when the doctor confirmed
the diagnosis. I was mentally prepared before visiting
the polyclinic and accept … hence when I knew the
truth I just accepted it.’ (60–69 year old, Chinese,
Stage II cancer).
‘My children cried and I asked what’s there to cry
about? I said people live and die. I was calm when
the doctor told me (about the diagnosis) too.’ (60–
69 year old, Chinese, Stage III cancer).
‘On the day of surgery, when I was on the surgery op-
erating theatre’s bed, I cried because I was thinking
why I am so unlucky that this is happening to me.
I’m not afraid of death or what … just sighing that I
am so unlucky to have this.’ (60–69 year old, Chin-
ese, Stage I cancer).
‘I was shocked. After that I broke down and cried. I
couldn’t accept it.’ (< 40 year old, Chinese, Stage III
cancer).
Anxiety over treatment cost
Some women worried about financial burden while
undergoing treatment.
‘A clinic visit costs over a hundred over dollars every
time... Consultation costs about $30, scans are at
least a hundred dollars, what about the weekly
blood tests if you go on chemotherapy. You have to
pay by cash. Therefore people say Singaporeans can
die but not fall sick.’ (60–69 year old, Chinese, Stage
III cancer).
‘I don’t want to burden my family. … my parents
were very sickly … I have eight siblings and we
couldn’t afford their medical bills. We were not edu-
cated and we earn about $1-2000 monthly, how is
that even enough to support our own family. … after
my parents passed on, its like a piece of shattered
glass … I have seen my parents’ condition and I
don’t want to burden my children. It is a hundred
over dollars every time. You can imagine how much
it costs when I visit these three places, What about
weekly blood test? It costs $30 every time I see the
doctor..’ (40–49 year old, Malay, Stage I cancer).
Indecision about post-surgery care
One patient described the process she went through to
decide if she should have a breast implant or tissue
grafting after her mastectomy.
‘Day one, you want. Day two, you don’t want. Day
three, you want. It’s a lot of back and forth and a lot
of opinions from people that influence you to see
whether you should. … Why do another surgery to
get … your breast back. … started looking the health
effects, the cost, the long term effects. Especially if
let’s say, the surgeon did suggest that I do an im-
plant, rather than a tissue grafting. Then you start
looking on internet and check, whether it is okay and
the long term effects. After weighing all the health …
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potential health risk, potential financial cost, and all
these things. I felt that it would, I’m not keen on the
tissue grafting, and I feel like it is two major surger-
ies. I already have one big one (surgery), I don’t want
another one, so that is sort of out. So I’m left with ei-
ther implant or with don’t have any reconstruction.
Implant was one of the potential problems that
comes with it, it’s going to last ten, fifteen year, but
who knows, it may not last ten or longer or maybe
shorter then you have more problem. So looking at
the cost (and) financial problems, what I want to do
from now on, so I felt that maybe it’s not necessary
after all. Although at one stage, I felt that I need it’
(40–49 year old, Chinese, Stage I cancer).
Diet and stress
Women talked about their acceptance that diet and
stress caused their cancer and made changes to the
lifestyle.
‘More concerned about whether any kinds of food
could be the cause … I gave up seafood except fish …
I still eat chicken because I believe chicken is white
meat, … I changed my eating habits by taking more
fruits. I am also of the opinion that cancer patients
like me are not disciplined. I think it’s about discip-
line with food.’ (60–69 year old, Chinese, Stage IV
cancer).
‘But now I understand that cancer could be due to
stress, the environment and food’ (< 40 year old, Chi-
nese,Stage III cancer).
‘Even now with the relapse, it could also be due to
stress, due to my work, like last time. So now I just
want to think less and not put too much pressure on
myself’ (50–59 year old, Malay,Stage II recurrent
breast cancer).
Traditional and complementary medicine
One patient reported turning to traditional and comple-
mentary medicine to cure the cancer after diagnosis. An-
other used traditional and complementary medicine to
cope with the side effects of treatment.
‘I went to the doctor at the polyclinic and was diag-
nosed with the cancer, then I went to see a trad-
itional healer. He said he will heal me. After 1
month, nothing happened, I came to the hospital
and they said I have to do chemotherapy … ’ (< 40
year old, Chinese, Stage IV cancer).
‘Actually I’m now looking for a TCM to improve my
health, as there are many side effects after
chemotherapy, like cough. After my second chemo-
therapy, I had a cough and it did not recover for two
months. After that I went to see a TCM until now.’
(< 40 year old, Chinese, Stage III cancer).
Recalling the efficiency of the breast cancer healthcare and
referral system
While one patient complained about her expectation to
be recalled by the hospital because she did not follow up
or missed her specialist appointment after her mammog-
raphy, others have praised the efficiency of the breast
health structure and referral system.
‘… Sometimes the patient might not follow up ac-
tively. But the hospital should have some form of fol-
low up, like sending a letter to advise the patient to
return to the hospital for a check-up and not wait
for a normal check up every two years. (60–69 year
old, Chinese, Stage II cancer).
Many patients appreciated the convenient and effi-
ciency of the breast health system in serving their needs.
‘When I was about to go home, they called to inform
me that there is an available slot on the same day,
So I went to the hospital immediately and did all
the necessary procedures.’ (60–69 year old, Chinese,
Stage III cancer).
‘I went to a clinic and the (doctor) told me it is (cancer).
He helped me make a call immediately, he called up
NUH and he said I could have (an appointment) in a
week.’ (60–69 year old, Chinese, Stage III cancer).
‘Polyclinic is the best, they do a check-up for you and
look for the relevant doctors … he immediately
called the (specialist) hospital when he felt some-
thing was wrong … getting an appointment through
them is very fast and cheap … you know a family
doctor will take 2 to 3 weeks and would be expen-
sive. I saw the doctor at 11 am that day and he
made me an appointment at 3 pm on the same day’
(60–69 year old, Chinese, Stage II cancer).
‘I called to make an appointment for the scan
(mammogram), but the staff asked me if I had a
lump, and recommended me to go to see the doctor
immediately instead’ (60–69 year old, Chinese, Stage
III cancer).
Prayers to god
The majority of Singaporeans are religious. Thus, it’s
natural that some patients turned to God to ask for re-
covery and miracles through the doctors.
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‘From my viewpoint of as Christian, god can still
heal through medical means, through doctors or
whatever. He can always do it, like using healing,
that sort of things’ (40–49 year old, Chinese, Stage I
cancer).
‘Well, of course prayer, prayer has always been part
of my life. So I believe God heals. But I think at the
same time, God provides the doctors and I think
God created all plants and animals for food. So I be-
lieve plant based there are many extracts used in
medicine these days. I think Soursop is one of the
known plants’ (40–49 year old, Indian, Stage I
cancer).
Support network
A central theme that transcended all sub-themes and re-
surfaced repeatedly was support network. It was able to
break down barriers that stemmed from both emotional
and structural origins. Family involvement was different
for each patient but the presence of family in itself was a
universally enabling factor for seeking specialist evalu-
ation after a diagnosis.
‘I don’t know what to do; my sister replied everything
for me. She did everything for me; I didn’t know
what to do’. (< 40 years old, Chinese, Stage IV
cancer).
‘We went home and discussed this (treatment)
method with our children, after all our children
already grown up, so we just discussed. I did not
want to wait any more longer, so we decided to go
on with the surgery because it’s only at the early
stage. We don’t need to let it worsen, so that’s why
as early as possible, we get it out.’ (40–49 year old,
Malay, Stage I cancer).
‘Even though I am a widow, I have both my children,
they are very supportive, I went (to the specialist)
with my daughter’ (Over 70 year old, Indian, Stage
II cancer).
‘My husband was with me at the point where they
talked about the results from the biopsy, so he was
the first person to know. He cried.’ (40–49 year old,
Indian, Stage I cancer).
‘My friend was present when I received my diagnosis.
We cried together. I went home and told my family.
My mother and the rest were sad, my father cried as
well. They don’t really believe it and asked me to do
another test.’ (< 40 year old, Chinese, Stage III
cancer).
Discussion
Our study is the first and only qualitative study specific-
ally exploring the help seeking behaviour and presenta-
tion of breast cancer among patients in Singapore. In
this paper, we were interested in the help seeking behav-
iour of patients regardless of the time they took to seek
medical attention after symptom discovery, and compare
this by stage of cancer, age and ethnicity. Because
tumour biology and aggressiveness is a prognostic factor
for stage of cancer at diagnosis, we purposefully did not
use any measure to categorise the patients into early or
late presenters. We found no pattern in the presentation
of symptoms by age and ethnic group, neither is there a
positive relationship between stage of cancer at diagnosis
and time delay (interval between symptom discovery and
first medical help seeking). Presentation of cancer also
did not appear to differ between the stages of cancer di-
agnosed, ethnic and age groups. These findings suggest
that a need for a definition or measure of late/delayed
presentation that is meaningful for patients, clinicians
and researchers [44] – one that accounts not only for
time interval, the cancer journey as experienced by the
patients, and the tumour biology.
We observed that women who presented early (less
than 3 months) or immediately were also diagnosed with
advanced stage cancer (Stages III and IV), and vice versa.
Apart from tumour biology which affects the cancer sta-
ging at diagnosis [48], this finding could be explained by
chance discovery, opportunistic health check and mam-
mography. The women would have no knowledge that
they had a palpable lump unless they regularly and cor-
rectly performed BSE, or had a health check and mam-
mography. Based on our clinical experience, a lump of 2
cm is usually palpable by the woman and the doctor;
since 75% of this patient group had tumour over 2 cm, it
can be assumed that these patients did not perform
regular BSE or correctly performing the techniques, and
discovered their symptom either by chance, or through
opportunistic health check and mammography and
sought medical advice, or they ignored the symptom and
delayed help seeking.
The length of time delay is assessed by the patient dir-
ectly and although there is concern about recall bias, it
has been observed that women were careful to record
the time when they first noticed their breast cancer
symptoms [43]. However, for an accurate time delay, re-
searchers would need to further establish if BSE was
performed regularly and correctly. Without this informa-
tion, validity of the time delay information is question-
able, as the information provided by the women did not
capture the exact period of delay when the lump became
palpable or atypical symptom manifested. Time delay
interval from symptom discovery to help seeking is not
an accurate measurement for patient delay unless further
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information on regular and correct BSE practice are col-
lected. For this group of women, it would appear that
BSE was not a common practice. Further, time delay
measure accounts only the time period between symp-
tom discovery and first medical consultation, and any
delay after diagnosis is not considered.
A third of the women in this patient group fell into
the BSS target screening age group and none reported
taking up the biennial invitation. Uptake of BSS mam-
mography screening in Singapore has been low; 90% of
women aged 50–69 years are aware of mammography as
a screening tool but less than 40% had ever taken up a
test [7]. Another study reported that cancer knowledge
predicts uptake - 41% of eligible women with limited
cancer knowledge compared to 68% with high cancer
knowledge had ever been for mammography screening
(p = 0.01) [22].
Without setting a measure to define early and late
presentation, we found that women shared similar ex-
perience affecting their breast cancer journey, regardless
of age, ethnicity and stage of cancer at diagnosis, in their
cancer journey. They reported poor knowledge of breast
cancer (symptoms and causes); few practised regular
BSE; denial of symptom; fear of hospitalisation, diagnosis
and treatment; worried and stress over financial burden
of treatment; misinformation in magazine and online
sources; diet; stress; caring responsibility; support net-
work; and use of alternative medicine before and after
diagnosis. Among these, strong social support; fear of
being an emotional and financial burden to the family,
and financial worries during treatment were recurring
themes. These findings are similar to studies that used a
time delay of 3 month and over to define delayed or late
presentation [18–20, 31, 41].
Existing evidence within Singapore suggested that
knowledge, educational level, patient perception of can-
cer and the efficacy of a screening program constitute
barriers to early presentation of breast cancer [22, 57,
58]. Our study concurred that a major barrier to presen-
tation that was consistent throughout the three groups
and across all age groups, was the lack of, and inaccurate
knowledge of cancer and its causes. However, we found
that this was evident even in younger patients with pro-
fessional degrees. This could be due to the inherent dis-
interest in a disease that the patients’ perceived as
unlikely to befall them or the disease of others. Patients
also equated cancer to death sentences resulting in fear
and an escapist mindset leading to delayed presentation.
A unique theme was the unwavering sense of personal
responsibility to the family and their careers. Women
had prioritized work and their family above their own
health, fiercely refusing to be a burden either emotion-
ally and financially to their family. This phenomenon is
likely borne from the influence of the Asian culture and
universal expectations of women in their multiple roles
as a wife, mother, daughter and income provider. Fur-
ther, many patients emphasised the importance of family
support in getting the care they need in their cancer
journey.
The global shift toward a healthy living culture with
meditation, health foods and exercise invariably popular-
izes alternative medicine. Though it has a role in specific
diseases, patients often mistake it as effective cancer
treatment thus delaying their presentation. A positive
impact of this trend is the heightened interest in BSE.
Women diagnosed with early stage breast cancer were
able to pick up abnormalities prompting them to seek
help early. While those with late stage disease either did
not examine their breasts altogether or did so with poor
technique and missed even large lesions. This empha-
sizes the need for education about BSE and skills to per-
form the technique correctly.
Singapore practices a co-payment healthcare scheme
urging citizens to participate actively in their healthcare.
As a healthcare hub, specialist centers such as the breast
center in National University Hospital, has triple assess-
ment housed within one unit. Clinical staffs are trained
to assist patients in their breast cancer journey, provid-
ing psychosocial and wound care services. Primary
healthcare practitioners have direct access to clinic ap-
pointment slots in order to facilitate a prompt and seam-
less workup and treatment. The convenient and
efficiency of the health care system for breast cancer re-
ferral from primary to secondary care was an enabling
factor for many patients. Patients reported visiting the
polyclinic for breast cancer symptom as their first health
access point, and then, immediately referred to the spe-
cialised breast clinic in secondary care for diagnosis.
They have praised these features, and the expertise of
their healthcare professionals. However, as a fee-for ser-
vice health system, the financial burden of the disease
had resulted in patients delaying help seeking, and for
some patients, had caused worries about their treatment
cost.
Our study is not without limitations. We recruited pa-
tients through their clinical team. This method could
have caused undue influence whereby patients might feel
obliged and agreed to participate in the study because
they were asked by the clinician or that they were in-
debted to the care they received. We did provide 24 to
48 h to the patients to consider participation and at the
start of the first meeting, while collecting informed con-
sent, we did assure patients that their standard of care
would not be violated should they decide not to partici-
pate or withdraw while in the midst of the study. An-
other limitation of our study is that we did not apply a
measure to define early and late presentation and thus,
restricts comparison with studies that used time delay or
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stage of cancer as measure. However, our approach pro-
vided another perspective to the analysis. We were able
to allude that other factors such as tumour characteris-
tics and aggressiveness are relevant in studying presenta-
tion and help seeking behaviour. Further, we showed
that time delay is not an accurate measure if information
of regular and correct technique to practice BSE are not
elicited.
Conclusion
There is no clear pattern of presentation for breast can-
cer by cancer stage at diagnosis, age and ethnicity in this
group of patients in Singapore. Regardless of when they
presented and/or took up treatment in their cancer jour-
ney, patients could still be diagnosed with advanced
stage cancer. Tumour biology plays an important role in
staging of cancer diagnosed, as well as whether women
practice regular and correct BSE technique. A measure
of breast cancer presentation - that accounts for the pa-
tient’s experience in their cancer journey, the time inter-
val and tumour biology – that is meaningful for patients,
clinicians and researchers is needed. For research on late
and delayed presentation, details on BSE practice – how
often, when and was it done correctly – will improve the
accuracy of time delay interval. For the public, concerted
efforts are urgent and critical to improve the knowledge
of breast cancer, survival and prognosis for early-
diagnosed cancer, the importance of regular and correct
technique to perform BSE, and to allay financial worries
of the disease in Singapore.
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